MENU

OTLK Outlook Therapeutics Forecast, Technical & Fundamental Analysis

a manufacturer of biosimilar versions of biopharmaceuticals

Industry Biotechnology
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OTLK is expected to report earnings to rise 22.92% to -98 cents per share on May 15

Outlook Therapeutics OTLK Stock Earnings Reports
Q1'24
Est.
$-0.98
Q4'23
Beat
by $0.19
Q3'23
Missed
by $0.94
Q2'23
Missed
by $1.55
Q1'23
Missed
by $0.54
The last earnings report on February 14 showed earnings per share of -80 cents, beating the estimate of -99 cents. With 552.86K shares outstanding, the current market capitalization sits at 34.06M.
A.I. Advisor
published General Information

General Information

a manufacturer of biosimilar versions of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
485 Route 1 South Building F
Phone
+1 609 619-3990
Employees
24
Web
https://www.outlooktherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

OTLK and Stocks

Correlation & Price change

A.I.dvisor tells us that OTLK and MCRB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLK and MCRB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
+0.70%
MCRB - OTLK
32%
Poorly correlated
-1.09%
VIR - OTLK
31%
Poorly correlated
-2.78%
STRO - OTLK
30%
Poorly correlated
+0.97%
CRSP - OTLK
30%
Poorly correlated
+0.88%
PASG - OTLK
29%
Poorly correlated
-7.15%
More